IDiyas

For the Inventor, By the Inventor

Suita, Japan

Matsuhiko Aratani

USPTO Granted Patents = 21

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 142(Granted Patents)


Location History:

  • Awaji-shinmachi, Higashiyodogawa-ku, Osaka, JP (1981)
  • Osaka, JP (1980 - 1982)
  • Awaji-Shimmachi, JP (1982)
  • Daitoh, JP (1985)
  • Suita, JP (1982 - 1989)
  • Daito, JP (1987 - 1990)

Company Filing History:

goldMedal20 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1980-1990

Loading Chart...
21 patents (USPTO):Explore Patents
1. 4898937 - .alpha.-crystals of cefazolin sodium (1990-02-06),
2. 4801580 - Peptide, process for preparation thereof and use thereof (1989-01-31),
3. 4749691 - Peptide, process for preparation thereof and use thereof (1988-06-07),
4. 4725582 - Peptide, process for preparation thereof and use thereof (1988-02-16),
5. 4666890 - Peptide, process for preparation thereof and use thereof (1987-05-19),
6. 4640915 - 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives (1987-02-03),
7. 4539155 - New peptide, process for preparation thereof and use thereof (1985-09-03),
8. 4539152 - 4-Substituted-2-oxoazetidine compounds (1985-09-03),
9. 4512980 - Peptide, process for preparation thereof and use thereof (1985-04-23),
10. 4504584 - Cultures of novel strains of Streptomyces (1985-03-12),
11. 4497738 - Analogous compounds of cephalosporins, processes for the preparation (1985-02-05),
12. 4487763 - Peptide, process for preparation thereof and use thereof (1984-12-11),
13. 4458078 - Oxazole derivatives (1984-07-03),
14. 4383945 - 4-Substituted-2-oxoazetidine compounds and processes for the preparation (1983-05-17),
15. 4369312 - Method of producing oxo-containing azetidinone compounds (1983-01-18),

Title: Innovations of Matsuhiko Aratani: A Journey Through Patents and Collaborations

Introduction: Matsuhiko Aratani is a distinguished inventor based in Suita, Japan, holding an impressive total of 21 patents. His work primarily focuses on advancements in pharmaceuticals, showcasing his dedication to improving medical therapies through innovative solutions.

Latest Patents: Among his notable inventions, two stand out for their significance in the field of medicine. The first is the development of alpha-crystals of cefazolin sodium, which exhibit a water content ranging from 13.0% to 15.8%. This specific formulation has proven to be effective as an antibiotic, demonstrating enhanced thermal and light stability. The second patent focuses on novel peptides with pharmacological activity, defined by the formula: ##STR1## where R^1 is hydrogen. These peptides are anticipated to have considerable impacts in therapeutic applications.

Career Highlights: Matsuhiko Aratani has contributed significantly to the pharmaceutical industry through his work with Fujisawa Pharmaceutical Company, Ltd. His career has been marked by a continuous pursuit of innovation, particularly in creating pharmaceutical compounds that address critical medical needs.

Collaborations: Throughout his career, Aratani has collaborated closely with notable colleagues, including Masashi Hashimoto and Keiji Hemmi. These partnerships have fostered a creative environment conducive to research and innovation, leading to the successful development of numerous patented inventions.

Conclusion: Matsuhiko Aratani’s prolific output of patents reflects his deep commitment to innovation in the pharmaceutical sector. His inventions, particularly in antibiotic development and peptide formulation, illustrate the vital role inventors play in advancing medical science and improving patient outcomes. As he continues to push the boundaries of scientific discovery, Aratani remains a pivotal figure in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…